APA (7th ed.) Citation

Zhang, C., Liu, Y., Guo, H., Peng, Y., Huang, L., Lu, S., & Wang, Z. (2025). Interleukin 21-Armed EGFR-VHH-CAR-T Cell Therapy for the Treatment of Esophageal Squamous Cell Carcinoma. MDPI AG.

Chicago Style (17th ed.) Citation

Zhang, Chenglin, Yanyan Liu, Haoran Guo, Ying Peng, Lei Huang, Shuangshuang Lu, and Zhimin Wang. Interleukin 21-Armed EGFR-VHH-CAR-T Cell Therapy for the Treatment of Esophageal Squamous Cell Carcinoma. MDPI AG, 2025.

MLA (9th ed.) Citation

Zhang, Chenglin, et al. Interleukin 21-Armed EGFR-VHH-CAR-T Cell Therapy for the Treatment of Esophageal Squamous Cell Carcinoma. MDPI AG, 2025.